KE3382A - Compounds and preparations for the treatment of theileriasis - Google Patents

Compounds and preparations for the treatment of theileriasis

Info

Publication number
KE3382A
KE3382A KE3382A KE338284A KE3382A KE 3382 A KE3382 A KE 3382A KE 3382 A KE3382 A KE 3382A KE 338284 A KE338284 A KE 338284A KE 3382 A KE3382 A KE 3382A
Authority
KE
Kenya
Prior art keywords
theileriasis
preparations
compounds
treatment
Prior art date
Application number
KE3382A
Other languages
English (en)
Inventor
Schein Eberhard
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of KE3382A publication Critical patent/KE3382A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KE3382A 1979-08-23 1984-03-01 Compounds and preparations for the treatment of theileriasis KE3382A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792934069 DE2934069A1 (de) 1979-08-23 1979-08-23 Mittel gegen theileriosen und seine verwendung.

Publications (1)

Publication Number Publication Date
KE3382A true KE3382A (en) 1984-03-23

Family

ID=6079087

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3382A KE3382A (en) 1979-08-23 1984-03-01 Compounds and preparations for the treatment of theileriasis

Country Status (14)

Country Link
US (1) US4340596A (fr)
BE (1) BE884917A (fr)
CH (1) CH649545A5 (fr)
DE (1) DE2934069A1 (fr)
EG (1) EG14600A (fr)
FR (2) FR2468368A1 (fr)
GB (1) GB2057439B (fr)
IL (1) IL60890A (fr)
KE (1) KE3382A (fr)
MA (1) MA18939A1 (fr)
MW (1) MW3080A1 (fr)
OA (1) OA06599A (fr)
ZM (1) ZM6780A1 (fr)
ZW (1) ZW19680A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1155358B (it) * 1982-07-06 1987-01-28 Vetem Spa Derivati chinazolinonici attivi contro la coccidiosi
US5017567A (en) * 1983-11-25 1991-05-21 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4906635A (en) * 1983-11-25 1990-03-06 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4778795A (en) * 1983-11-25 1988-10-18 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4762838A (en) * 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4797486A (en) * 1986-09-08 1989-01-10 Pfizer Inc. Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents
DE3638445A1 (de) * 1986-11-11 1988-05-26 Hoechst Ag Coccidiozide mittel
US4849518A (en) * 1987-06-22 1989-07-18 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
US4920224A (en) * 1988-03-24 1990-04-24 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents
AU3467493A (en) * 1992-01-27 1993-09-01 Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
IL112125A (en) * 1994-12-22 1998-02-08 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions
US5998422A (en) * 1994-12-12 1999-12-07 Agricultural Research Organization, Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
US6090814A (en) * 1995-08-15 2000-07-18 Agricultural Research Organization Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
EP0936910B1 (fr) * 1996-08-30 2002-07-24 Agricultural Research Organization, Ministry Of Agriculture, State Of Israel Extenseurs intracoronariens contenant des derives quinazolinone
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
WO2000009070A2 (fr) * 1998-08-13 2000-02-24 Hadasit Medical Research Services And Development Company Ltd. Inhibition de procedes lies a des lesions tissulaires
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
AU2006217453A1 (en) * 2005-02-23 2006-08-31 Collgard Biopharmaceuticals Ltd. Pharmaceutical compositions of the isolated D- enantiomer of the quinazolinone derivative halofuginone
WO2007120606A2 (fr) * 2006-04-10 2007-10-25 President And Fellows Of Harvard College Procédés de modulation de la formation et de la progression de la cellulite
WO2009023267A2 (fr) * 2007-08-15 2009-02-19 President And Fellows Of Harvard College Procédé de modulation du développement et de l'expansion de cellules exprimant il-17
CN102177152A (zh) * 2008-08-11 2011-09-07 哈佛大学校长及研究员协会 用于抑制tRNA合成酶的卤夫酮(halofuginone)类似物和其用途
US10155742B2 (en) 2012-01-13 2018-12-18 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
EP2845588A1 (fr) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) Inhibiteurs PIN1 destiné à être utilisé dans la prévention et/ou le traitement de theileriosis et applications associées
EP3801525A4 (fr) 2018-06-08 2022-03-23 The General Hospital Corporation Inhibiteurs de la prolyl-arnt-synthétase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505711A (fr) * 1950-09-09
US2694711A (en) * 1952-12-02 1954-11-16 American Cyanamid Co Quinazolone antimalarial compounds
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones

Also Published As

Publication number Publication date
FR2468368A1 (fr) 1981-05-08
US4340596A (en) 1982-07-20
DE2934069A1 (de) 1981-03-12
GB2057439B (en) 1983-06-22
OA06599A (fr) 1981-08-31
DE2934069C2 (fr) 1990-02-15
GB2057439A (en) 1981-04-01
IL60890A0 (en) 1980-10-26
BE884917A (fr) 1981-02-25
IL60890A (en) 1983-09-30
CH649545A5 (de) 1985-05-31
FR2468602B1 (fr) 1983-07-22
FR2468368B1 (fr) 1983-07-08
MA18939A1 (fr) 1981-04-01
MW3080A1 (en) 1981-08-12
ZW19680A1 (en) 1981-03-11
EG14600A (en) 1985-03-31
FR2468602A1 (fr) 1981-05-08
ZM6780A1 (en) 1981-10-21

Similar Documents

Publication Publication Date Title
KE3382A (en) Compounds and preparations for the treatment of theileriasis
PH24427A (en) Treatment of dysmanorrhea
EG14076A (en) 6-n-propyl 1-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB2059424B (en) Treatment of scrap
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
IL61005A0 (en) Method for the manufacture of dentures and device for carrying out the method
GB2063870B (en) 1-aryl-4-arylsulphonyl-1h-pyrazolol-3 compounds and processes for their preparation
DE3173016D1 (en) Preparations for the treatment of dermatoses
IL61143A0 (en) 6-n-propyl-8alpha-methoxymethyl or methylmercaptomethylergolines and related compounds
AU538641B2 (en) Treatment of cattle
GB2058063B (en) Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers
JPS5686153A (en) Mercaptoacylldisubstituteddproline derivative and relative compounds
IL59764A0 (en) Drug on the basis of dihydroergo-toxine and procedure for its manufacture
MY8500127A (en) Analgesic and myotonolytic preparations
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
ZW15180A1 (en) Aminothiadiazolyl compounds processes for the manufacture thereof and pharmaceutical preparations containing such compounds and the use thereof
ZA802582B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
GB2048069B (en) Medicinal preparations for treating carcinomas
JPS56893A (en) Treatment of moxious matter compound
DE3069392D1 (en) Method for the preparation of molybdenum-surface-compounds and their uses
PH17058A (en) Dea-steroids,pharmaceutical preparations containing the same and method of use thereof
ZA79449B (en) Therapeutic method for the treatment of hyperlipoproteinaemias and hyperlipodaemias
AU533380B2 (en) Treatment of scrap
ZA80551B (en) Composition for the treatment of cold sores and the like
ZA802142B (en) Analgesic and myotonolytic preparations